Back to Search Start Over

Perioperative Nivolumab Tops Chemo for Survival in Resectable Lung Cancer

Source :
MPR Monthly Prescribing Reference. May 18, 2024
Publication Year :
2024

Abstract

HealthDay News — For patients with resectable non-small cell lung cancer (NSCLC), perioperative treatment with nivolumab results in significantly longer event-free survival, according to a study published in the May [...]

Subjects

Subjects :
Diseases -- Relapse
Chemotherapy -- Reports
Lung cancer, Non-small cell -- Development and progression -- Drug therapy
Cancer -- Chemotherapy
Health

Details

Language :
English
ISSN :
08830266
Database :
Gale General OneFile
Journal :
MPR Monthly Prescribing Reference
Publication Type :
Periodical
Accession number :
edsgcl.794185914

Tools

Authors Abstract Subjects Details